posted on 2024-08-05, 15:33authored byZhi-Qiang Chen, Ru-Jie Yang, Chao-Wei Zhu, Yang Li, Ru Yan, Jian-Bo Wan
Glucuronidation, a crucial process in phase II metabolism,
plays
a vital role in the detoxification and elimination of endogenous substances
and xenobiotics. A comprehensive and confident profiling of glucuronate-conjugated
metabolites is imperative to understanding their roles in physiological
and pathological processes. In this study, a chemical isotope labeling
and dual-filtering strategy was developed for global profiling of
glucuronide metabolites in biological samples. N,N-Dimethyl ethylenediamine (DMED-d0) and its deuterated counterpart DMED-d6 were used to label carboxylic acids through an amidation
reaction. First, carboxyl-containing compounds were extracted based
on a characteristic mass difference (Δm/z, 6.037 Da) observed in MS between light- and heavy-labeled
metabolites (filter I). Subsequently, within the pool of carboxyl-containing
compounds, glucuronides were identified using two pairs of diagnostic
ions (m/z 247.1294/253.1665 and
229.1188/235.1559 for DMED-d0/DMED-d6-labeled glucuronides) originating from the
fragmentation of the derivatized glucuronic acid group in MS/MS (filter
II). Compared with non-derivatization, DEMD labeling significantly
enhanced the detection sensitivity of glucuronides, as evidenced by
a 3- to 55-fold decrease in limits of detection for representative
standards. The strategy was applied to profiling glucuronide metabolites
in urine samples from colorectal cancer (CRC) patients. A total of
685 features were screened as potential glucuronides, among which
181 were annotated, mainly including glucuronides derived from lipids,
organic oxygen, and phenylpropanoids. Enzymatic biosynthesis was employed
to accurately identify unknown glucuronides without standards, demonstrating
the reliability of the dual-filtering strategy. Our strategy exhibits
great potential for profiling the glucuronide metabolome with high
coverage and confidence to reveal changes in CRC and other diseases.